只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-20 2026-07-21 | BFLY Butterfly Network, Inc. | DEVIVO JOSEPH Director,Officer · President & CEO | 卖出（S） | 211,798 | US$6.56 | US$138.94万 | 7,672,046 | SEC |
| 2026-07-16 2026-07-20 | CERS CERUS CORP | Jayaraman Vivek K Officer · Chief Executive Officer | 卖出（S） | 16,666 | US$3.16 | US$52,664.56 | 2,232,211 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | VANI Vivani Medical, Inc. | Williams Gregg Director,TenPercentOwner | 买入（P） | 793,650 | US$1.26 | US$999,999.00 | 36,912,736 | SEC |
| 2026-07-15 2026-07-15 | RDGL VIVOS INC | Korenko Michael K Director,Officer · CEO AND PRESIDENT | 买入（P） | 200,000 | US$0.06 | US$11,420.00 | 11,285,090 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-10 2026-07-10 | RDGL VIVOS INC | Weeks Brad Allan Officer · President | 买入（P） | 12,000 | US$0.08 | US$960.00 | 999,235 | SEC |
| 2026-07-09 2026-07-10 | RDGL VIVOS INC | Weeks Brad Allan Officer · President | 买入（P） | 48,000 | US$0.08 | US$3,840.00 | 987,235 | SEC |
| 2026-07-07 2026-07-08 | BFLY Butterfly Network, Inc. | DEVIVO JOSEPH Director,Officer · President & CEO | 卖出（S） | 204,725 | US$7.87 | US$161.18万 | 7,883,844 | SEC |
| 2026-07-02 2026-07-07 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio Director | 卖出（S） | 3,000 | US$40.00 | US$120,000.00 | 19,225 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 545 | US$1.54 | US$839.30 | 718,989 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 545 | US$1.54 | US$839.30 | 718,989 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 545 | US$1.54 | US$839.30 | 718,989 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 545 | US$1.54 | US$839.30 | 718,989 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 55 | US$1.54 | US$84.70 | 72,590 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 55 | US$1.54 | US$84.70 | 72,590 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 55 | US$1.54 | US$84.70 | 72,590 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 55 | US$1.54 | US$84.70 | 72,590 | SEC |
| 2026-06-30 2026-07-02 | CERS CERUS CORP | Jayaraman Vivek K Officer · Chief Operating Officer | 卖出（S） | 42,359 | US$2.94 | US$124,658.30 | 1,694,348 | SEC |
| 2026-06-18 2026-06-22 | OFIX Orthofix Medical Inc. | McPherron Aviva Officer · Pres, Global Ops & Qual | 卖出（S） | 3,670 | US$9.38 | US$34,424.60 | 66,330 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 4,222 | US$507.43 | US$214.24万 | 6,829,166.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 2,156 | US$508.50 | US$109.63万 | 6,827,010.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 6,523 | US$509.54 | US$332.37万 | 6,820,487.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 6,456 | US$510.43 | US$329.53万 | 6,814,031.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 6,177 | US$511.59 | US$316.01万 | 6,807,854.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 153 | US$494.84 | US$75,710.52 | 6,948,844.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 3,754 | US$495.49 | US$186.01万 | 6,945,090.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 4,695 | US$496.49 | US$233.1万 | 6,940,395.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 13,628 | US$497.50 | US$677.99万 | 6,926,767.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 19,421 | US$498.52 | US$968.18万 | 6,907,346.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 17,871 | US$499.46 | US$892.58万 | 6,889,475.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 10,683 | US$512.54 | US$547.55万 | 6,797,171.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 5,260 | US$513.39 | US$270.04万 | 6,791,911.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 5,311 | US$514.35 | US$273.17万 | 6,786,600.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 408 | US$515.14 | US$210,177.12 | 6,786,192.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 100 | US$516.81 | US$51,681.00 | 6,786,092.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 70 | US$517.60 | US$36,232.00 | 6,786,022.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 547 | US$518.22 | US$283,466.34 | 6,785,475.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 40 | US$519.50 | US$20,780.00 | 6,785,435.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 348 | US$520.30 | US$181,064.40 | 6,785,087.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 4,869 | US$500.39 | US$243.64万 | 6,884,606.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 5,895 | US$501.43 | US$295.59万 | 6,878,711.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 6,991 | US$502.61 | US$351.37万 | 6,871,720.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 11,122 | US$503.50 | US$559.99万 | 6,860,598.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 9,693 | US$504.42 | US$488.93万 | 6,850,905.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 9,319 | US$505.46 | US$471.04万 | 6,841,586.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 8,198 | US$506.45 | US$415.19万 | 6,833,388.25 | SEC |
| 2026-06-16 2026-06-17 | SNOW Snowflake Inc. | Raghunathan Vivek Officer · SVP, Engineering | 卖出（S） | 3,876 | US$240.00 | US$930,240.00 | 258,689 | SEC |
| 2026-06-15 2026-06-16 | VANI Vivani Medical, Inc. | Williams Gregg Director,TenPercentOwner | 买入（P） | 1,587,301 | US$1.26 | US$200万 | 36,119,086 | SEC |
| 2026-06-12 2026-06-15 | SEAT Vivid Seats Inc. | Arnett Austin Officer · General Counsel | 卖出（S） | 62 | US$8.36 | US$518.32 | 4,865 | SEC |
| 2026-06-09 2026-06-11 | PETV PetVivo Holdings, Inc. | A.L. Sarroff Fund, LLC TenPercentOwner | 买入（P） | 187,500 | US$0.00 | US$0.00 | 10,439,729 | SEC |
| 2026-06-08 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 2,982 | US$1.52 | US$4,532.64 | 72,535 | SEC |
| 2026-06-08 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 2,982 | US$1.52 | US$4,532.64 | 72,535 | SEC |
| 2026-06-08 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 2,982 | US$1.52 | US$4,532.64 | 72,535 | SEC |
| 2026-06-08 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 2,982 | US$1.52 | US$4,532.64 | 72,535 | SEC |
| 2026-06-08 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 29,518 | US$1.52 | US$44,867.36 | 718,444 | SEC |
| 2026-06-08 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 29,518 | US$1.52 | US$44,867.36 | 718,444 | SEC |
| 2026-06-08 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 29,518 | US$1.52 | US$44,867.36 | 718,444 | SEC |
| 2026-06-08 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 29,518 | US$1.52 | US$44,867.36 | 718,444 | SEC |
| 2026-06-05 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 49,966 | US$1.57 | US$78,446.62 | 688,926 | SEC |
| 2026-06-05 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 49,966 | US$1.57 | US$78,446.62 | 688,926 | SEC |
| 2026-06-05 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 49,966 | US$1.57 | US$78,446.62 | 688,926 | SEC |
| 2026-06-05 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 49,966 | US$1.57 | US$78,446.62 | 688,926 | SEC |
| 2026-06-05 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 5,045 | US$1.57 | US$7,920.65 | 69,553 | SEC |
| 2026-06-05 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 5,045 | US$1.57 | US$7,920.65 | 69,553 | SEC |
| 2026-06-05 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 5,045 | US$1.57 | US$7,920.65 | 69,553 | SEC |
| 2026-06-05 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 5,045 | US$1.57 | US$7,920.65 | 69,553 | SEC |
| 2026-06-04 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 6,125 | US$1.57 | US$9,616.25 | 638,960 | SEC |
| 2026-06-04 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 6,125 | US$1.57 | US$9,616.25 | 638,960 | SEC |
| 2026-06-04 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 6,125 | US$1.57 | US$9,616.25 | 638,960 | SEC |
| 2026-06-04 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 6,125 | US$1.57 | US$9,616.25 | 638,960 | SEC |
| 2026-06-04 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 618 | US$1.57 | US$970.26 | 64,508 | SEC |
| 2026-06-04 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 618 | US$1.57 | US$970.26 | 64,508 | SEC |
| 2026-06-04 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 618 | US$1.57 | US$970.26 | 64,508 | SEC |
| 2026-06-04 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 618 | US$1.57 | US$970.26 | 64,508 | SEC |
| 2026-06-03 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 7,069 | US$1.55 | US$10,956.95 | 632,835 | SEC |
| 2026-06-03 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 7,069 | US$1.55 | US$10,956.95 | 632,835 | SEC |
| 2026-06-03 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 7,069 | US$1.55 | US$10,956.95 | 632,835 | SEC |
| 2026-06-03 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 7,069 | US$1.55 | US$10,956.95 | 632,835 | SEC |
| 2026-06-03 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 714 | US$1.55 | US$1,106.70 | 63,890 | SEC |
| 2026-06-03 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 714 | US$1.55 | US$1,106.70 | 63,890 | SEC |
| 2026-06-03 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 714 | US$1.55 | US$1,106.70 | 63,890 | SEC |
| 2026-06-03 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 714 | US$1.55 | US$1,106.70 | 63,890 | SEC |
| 2026-06-02 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 20,753 | US$1.52 | US$31,544.56 | 625,766 | SEC |
| 2026-06-02 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 20,753 | US$1.52 | US$31,544.56 | 625,766 | SEC |
| 2026-06-02 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 20,753 | US$1.52 | US$31,544.56 | 625,766 | SEC |
| 2026-06-02 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 20,753 | US$1.52 | US$31,544.56 | 625,766 | SEC |
| 2026-06-02 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 2,095 | US$1.52 | US$3,184.40 | 63,176 | SEC |
| 2026-06-02 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 2,095 | US$1.52 | US$3,184.40 | 63,176 | SEC |
| 2026-06-02 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 2,095 | US$1.52 | US$3,184.40 | 63,176 | SEC |
| 2026-06-02 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 2,095 | US$1.52 | US$3,184.40 | 63,176 | SEC |
| 2026-06-01 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 14,838 | US$1.55 | US$22,998.90 | 605,013 | SEC |
| 2026-06-01 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 14,838 | US$1.55 | US$22,998.90 | 605,013 | SEC |
| 2026-06-01 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 14,838 | US$1.55 | US$22,998.90 | 605,013 | SEC |
| 2026-06-01 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 14,838 | US$1.55 | US$22,998.90 | 605,013 | SEC |
| 2026-06-01 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,498 | US$1.55 | US$2,321.90 | 61,081 | SEC |
| 2026-06-01 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,498 | US$1.55 | US$2,321.90 | 61,081 | SEC |
| 2026-06-01 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,498 | US$1.55 | US$2,321.90 | 61,081 | SEC |
| 2026-06-01 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,498 | US$1.55 | US$2,321.90 | 61,081 | SEC |
| 2026-05-29 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 16,164 | US$1.57 | US$25,377.48 | 590,175 | SEC |
| 2026-05-29 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 16,164 | US$1.57 | US$25,377.48 | 590,175 | SEC |
| 2026-05-29 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 16,164 | US$1.57 | US$25,377.48 | 590,175 | SEC |
| 2026-05-29 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 16,164 | US$1.57 | US$25,377.48 | 590,175 | SEC |
| 2026-05-29 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,632 | US$1.57 | US$2,562.24 | 59,583 | SEC |
| 2026-05-29 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,632 | US$1.57 | US$2,562.24 | 59,583 | SEC |
| 2026-05-29 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,632 | US$1.57 | US$2,562.24 | 59,583 | SEC |
| 2026-05-29 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,632 | US$1.57 | US$2,562.24 | 59,583 | SEC |
| 2026-05-29 2026-06-02 | CERS CERUS CORP | Jayaraman Vivek K Officer · Chief Operating Officer | 卖出（S） | 16,667 | US$3.00 | US$50,001.00 | 1,656,707 | SEC |
| 2026-05-28 2026-06-01 | JBLU JETBLUE AIRWAYS CORP | Sharma Vivek Director | 卖出（S） | 26,415 | US$5.41 | US$142,905.15 | 36,064 | SEC |
| 2026-05-28 2026-06-01 | JBLU JETBLUE AIRWAYS CORP | Sharma Vivek Director | 卖出（S） | 585 | US$5.42 | US$3,170.70 | 35,479 | SEC |
| 2026-05-28 2026-06-01 | JBLU JETBLUE AIRWAYS CORP | Sharma Vivek Director | 卖出（S） | 5,000 | US$5.40 | US$27,000.00 | 62,479 | SEC |
| 2026-05-22 2026-05-26 | PETV PetVivo Holdings, Inc. | A.L. Sarroff Fund, LLC TenPercentOwner | 买入（P） | 250,000 | US$0.40 | US$100,000.00 | 10,452,229 | SEC |
| 2026-05-21 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 30,882 | US$1.69 | US$52,190.58 | 574,011 | SEC |
| 2026-05-21 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 30,882 | US$1.69 | US$52,190.58 | 574,011 | SEC |
| 2026-05-21 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 30,882 | US$1.69 | US$52,190.58 | 574,011 | SEC |
| 2026-05-21 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 30,882 | US$1.69 | US$52,190.58 | 574,011 | SEC |
| 2026-05-21 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 3,118 | US$1.69 | US$5,269.42 | 57,951 | SEC |
| 2026-05-21 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 3,118 | US$1.69 | US$5,269.42 | 57,951 | SEC |
| 2026-05-21 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 3,118 | US$1.69 | US$5,269.42 | 57,951 | SEC |
| 2026-05-21 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 3,118 | US$1.69 | US$5,269.42 | 57,951 | SEC |
| 2026-05-21 2026-05-26 | PHVS Pharvaris N.V. | Monges Viviane Director | 卖出（S） | 9,667 | US$30.29 | US$292,813.43 | 5,500 | SEC |
| 2026-05-20 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 51,056 | US$1.56 | US$79,647.36 | 543,129 | SEC |
| 2026-05-20 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 51,056 | US$1.56 | US$79,647.36 | 543,129 | SEC |
| 2026-05-20 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 51,056 | US$1.56 | US$79,647.36 | 543,129 | SEC |
| 2026-05-20 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 51,056 | US$1.56 | US$79,647.36 | 543,129 | SEC |
| 2026-05-20 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 5,154 | US$1.56 | US$8,040.24 | 54,833 | SEC |
| 2026-05-20 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 5,154 | US$1.56 | US$8,040.24 | 54,833 | SEC |
| 2026-05-20 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 5,154 | US$1.56 | US$8,040.24 | 54,833 | SEC |
| 2026-05-20 2026-06-10 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 5,154 | US$1.56 | US$8,040.24 | 54,833 | SEC |
| 2026-05-19 2026-05-21 | DINO HF Sinclair Corp | Garg Vivek Officer · Acting CFO, VP, CAO & CONTR | 卖出（S） | 717 | US$71.89 | US$51,545.13 | 11,475 | SEC |
| 2026-05-15 2026-05-19 | VANI Vivani Medical, Inc. | Williams Gregg Director,TenPercentOwner | 买入（P） | 1,587,301 | US$1.26 | US$200万 | 34,531,785 | SEC |
| 2026-05-13 2026-05-14 | SEAT Vivid Seats Inc. | Arnett Austin Officer · General Counsel | 卖出（S） | 10 | US$8.53 | US$85.30 | 2,699 | SEC |
| 2026-05-11 2026-05-11 | RDGL VIVOS INC | Korenko Michael K Director,Officer · CEO AND PRESIDENT | 买入（P） | 150,000 | US$0.06 | US$9,000.00 | 11,085,090 | SEC |
| 2026-05-07 2026-06-02 | DVLT Datavault AI Inc. | Vivasor, Inc. TenPercentOwner | 卖出（S） | 2,535,083 | US$0.50 | US$126.75万 | 55,942,666 | SEC |
| 2026-05-06 2026-06-02 | DVLT Datavault AI Inc. | Vivasor, Inc. TenPercentOwner | 卖出（S） | 2,267,338 | US$0.55 | US$124.7万 | 58,477,749 | SEC |
| 2026-05-05 2026-06-02 | DVLT Datavault AI Inc. | Vivasor, Inc. TenPercentOwner | 卖出（S） | 5,071,311 | US$0.57 | US$289.06万 | 60,745,087 | SEC |
| 2026-05-04 2026-06-02 | DVLT Datavault AI Inc. | Vivasor, Inc. TenPercentOwner | 卖出（S） | 10,126,268 | US$0.58 | US$587.32万 | 65,816,398 | SEC |
| 2026-05-04 2026-05-05 | TXN TEXAS INSTRUMENTS INC | Ilan Haviv Director,Officer · Chairman, President & CEO | 卖出（S） | 20,000 | US$280.32 | US$560.64万 | 204,339 | SEC |
| 2026-05-01 2026-05-05 | CERS CERUS CORP | Jayaraman Vivek K Officer · Chief Operating Officer | 卖出（S） | 16,667 | US$3.00 | US$50,001.00 | 1,673,374 | SEC |
| 2026-04-15 2026-04-16 | VANI Vivani Medical, Inc. | Williams Gregg Director,TenPercentOwner | 买入（P） | 1,587,301 | US$1.26 | US$200万 | 32,944,484 | SEC |
| 2026-04-01 2026-04-02 | SNOW Snowflake Inc. | Raghunathan Vivek Officer · SVP, Engineering | 卖出（S） | 3,876 | US$152.80 | US$592,252.80 | 273,323 | SEC |
| 2026-03-31 2026-04-02 | VVOS Vivos Therapeutics, Inc. | V-Co Investors 3 LLC TenPercentOwner | 买入（P） | 308,848 | US$1.34 | US$413,856.32 | 1,353,625 | SEC |
| 2026-03-31 2026-04-02 | VVOS Vivos Therapeutics, Inc. | Skaff Michael C TenPercentOwner | 买入（P） | 308,848 | US$1.34 | US$413,856.32 | 1,353,625 | SEC |
| 2026-03-31 2026-04-02 | VVOS Vivos Therapeutics, Inc. | V-Co Investors 3 LLC TenPercentOwner | 买入（P） | 1,044,777 | US$1.34 | US$140万 | 1,044,777 | SEC |
| 2026-03-31 2026-04-02 | VVOS Vivos Therapeutics, Inc. | Skaff Michael C TenPercentOwner | 买入（P） | 1,044,777 | US$1.34 | US$140万 | 1,044,777 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| TVIV | 72 | 0 | 75 | 96.00% | Q |
| AVIV | 38,543.0863 | 0 | 52,718.8106 | 73.11% | Q, N |
| VIVO | 118,727.7901 | 876 | 187,750.0661 | 63.24% | B, Q, N |
| VIVK | 1,206,478.4621 | 298,348 | 2,115,807.2393 | 57.02% | B, Q, N |
| VIVS | 938,878.2318 | 112,385 | 1,951,381.1444 | 48.11% | B, Q, N |
| VIV | 137,798.1098 | 0 | 350,885.0588 | 39.27% | B, Q, N |